mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.006 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |